Clinical efficacy and tolerability of a novel selective corticosteroid in atopic dermatitis--two randomised controlled trials
- PMID:25614148
- DOI: 10.1159/000367696
Clinical efficacy and tolerability of a novel selective corticosteroid in atopic dermatitis--two randomised controlled trials
Abstract
Topical corticosteroids remain the first-line therapy for atopic dermatitis (AD). Hence, we investigated the efficacy and safety profile of a novel selective corticosteroid, GW870086. We performed 2 randomised, double-blind, controlled studies with 25 AD patients and 20 healthy subjects. The changes in the Three-Item Severity (TIS) score and the skin thickness were the primary end points, respectively. The adjusted TIS score (day 22) shows that the novel corticosteroid resulted in a non-significant, but dose-dependent reduction compared to placebo (GW870086 0.2% vs. placebo = -0.38, GW870086 2% vs. placebo = -0.89). Significant skin thinning was observed in the second study on days 14 and 21 when patients were treated with the comparator but not with the novel corticosteroid compared to placebo. The clinical efficacy of the new selective corticosteroid was not superior to placebo, although a dose-dependent improvement upon treatment was noticed without the onset of skin thinning.
Trial registration: ClinicalTrials.govNCT00549497.
© 2015 S. Karger AG, Basel.
Similar articles
- Probiotic supplement reduces atopic dermatitis in preschool children: a randomized, double-blind, placebo-controlled, clinical trial.Gerasimov SV, Vasjuta VV, Myhovych OO, Bondarchuk LI.Gerasimov SV, et al.Am J Clin Dermatol. 2010;11(5):351-61. doi: 10.2165/11531420-000000000-00000.Am J Clin Dermatol. 2010.PMID:20642296Clinical Trial.
- The efficacy of whey associated with dodder seed extract on moderate-to-severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled clinical trial.Mehrbani M, Choopani R, Fekri A, Mehrabani M, Mosaddegh M, Mehrabani M.Mehrbani M, et al.J Ethnopharmacol. 2015 Aug 22;172:325-32. doi: 10.1016/j.jep.2015.07.003. Epub 2015 Jul 4.J Ethnopharmacol. 2015.PMID:26151244Clinical Trial.
- Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.Stainer R, Matthews S, Arshad SH, McDonald S, Robinson J, Schapira C, Foote KD, Baird-Snell M, Gregory T, Pollock I, Stevens MT, Edwards AM.Stainer R, et al.Br J Dermatol. 2005 Feb;152(2):334-41. doi: 10.1111/j.1365-2133.2004.06303.x.Br J Dermatol. 2005.PMID:15727648Clinical Trial.
- A systematic review of the safety and efficacy of systemic corticosteroids in atopic dermatitis.Yu SH, Drucker AM, Lebwohl M, Silverberg JI.Yu SH, et al.J Am Acad Dermatol. 2018 Apr;78(4):733-740.e11. doi: 10.1016/j.jaad.2017.09.074. Epub 2017 Dec 6.J Am Acad Dermatol. 2018.PMID:29032119Review.
- What's new in the topical treatment of allergic skin diseases.Aslam I, Sandoval LF, Feldman SR.Aslam I, et al.Curr Opin Allergy Clin Immunol. 2014 Oct;14(5):436-50. doi: 10.1097/ACI.0000000000000093.Curr Opin Allergy Clin Immunol. 2014.PMID:25061854Review.
Cited by
- Topical anti-inflammatory treatments for eczema: network meta-analysis.Lax SJ, Van Vogt E, Candy B, Steele L, Reynolds C, Stuart B, Parker R, Axon E, Roberts A, Doyle M, Chu DK, Futamura M, Santer M, Williams HC, Cro S, Drucker AM, Boyle RJ.Lax SJ, et al.Cochrane Database Syst Rev. 2024 Aug 6;8(8):CD015064. doi: 10.1002/14651858.CD015064.pub2.Cochrane Database Syst Rev. 2024.PMID:39105474Free PMC article.Review.
- Strategies for using topical corticosteroids in children and adults with eczema.Lax SJ, Harvey J, Axon E, Howells L, Santer M, Ridd MJ, Lawton S, Langan S, Roberts A, Ahmed A, Muller I, Ming LC, Panda S, Chernyshov P, Carter B, Williams HC, Thomas KS, Chalmers JR.Lax SJ, et al.Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013356. doi: 10.1002/14651858.CD013356.pub2.Cochrane Database Syst Rev. 2022.PMID:35275399Free PMC article.Review.
- Characterization of a novel non-steroidal glucocorticoid receptor agonist optimized for topical treatment.Eirefelt S, Stahlhut M, Svitacheva N, Carnerup MA, Da Rosa JMC, Ewald DA, Marstrand TT, Krogh-Madsen M, Dünstl G, Dack KN, Ollerstam A, Norsgaard H.Eirefelt S, et al.Sci Rep. 2022 Jan 27;12(1):1501. doi: 10.1038/s41598-022-05471-w.Sci Rep. 2022.PMID:35087193Free PMC article.
- Improved Glucocorticoid Receptor Ligands: Fantastic Beasts, but How to Find Them?Van Moortel L, Gevaert K, De Bosscher K.Van Moortel L, et al.Front Endocrinol (Lausanne). 2020 Sep 24;11:559673. doi: 10.3389/fendo.2020.559673. eCollection 2020.Front Endocrinol (Lausanne). 2020.PMID:33071974Free PMC article.Review.
- Compound traditional Chinese medicine dermatitis ointment ameliorates inflammatory responses and dysregulation of itch-related molecules in atopic dermatitis.Zhang R, Zhang H, Shao S, Shen Y, Xiao F, Sun J, Piao S, Zhao D, Li G, Yan M.Zhang R, et al.Chin Med. 2022 Jan 4;17(1):3. doi: 10.1186/s13020-021-00555-7.Chin Med. 2022.PMID:34983579Free PMC article.
Publication types
MeSH terms
Substances
Associated data
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical